Showing results (971-980 of 1,376) with videos related to

Sort By:
Pageof 138
Drug Development Research|November 20, 2023
Anti-allodynic and anti-hyperalgesic activity of (±)-licarin A in neuropathic rats via NO-cyclic-GMP-ATP-sensitive K+ channel pathwayLiliana Hernández-Vázquez, Brian Colín-Martínez, María Guadalupe Lara-Ruíz, et al.
Drug Development Research|August 17, 2023
FDA Modernization Act 2.0: An insight from nondeveloping countrySajidur Rahman Akash, M A Jobayer Billah Arnob, Md Jamal Uddin
Drug Development Research|September 4, 2023
Design, synthesis, and antitumor screening of new thiazole, thiazolopyrimidine, and thiazolotriazine derivatives as potent inhibitors of VEGFR-2Alaa A Abd Elhameed, Ahmed R Ali, Hazem A Ghabbour, et al.
Drug Development Research|September 7, 2023
Tryptamine: A privileged scaffold for the management of Alzheimer's diseaseYash P Singh, Harish Kumar
Drug Development Research|September 11, 2023
Carbamate as a potential anti-Alzheimer's pharmacophore: A reviewYash Pal Singh, Navneet Kumar, Brijesh Singh Chauhan, et al.
Drug Development Research|July 1, 2023
Exosome-mediated PROTACs delivery to target viral infectionsNobendu Mukerjee, Swastika Maitra, Arabinda Ghosh, et al.
Drug Development Research|March 2, 2026
Design and Synthesis of Novel Lonidamine-N-Heterocyclic Derivatives With Potent Anticancer Activity Against Colorectal Cancer CellsRaveendra Madhukar Bhat, Priyadarshini An, Gangadhar V Muddapur, et al.
Drug Development Research|March 30, 2026
Thiazole-Semicarbazone Hybrids as Dual-Stage Inhibitors of Leishmania major Growth: Design, Synthesis, and Mechanistic InsightsMoataz A Shaldam, Haytham O Tawfik, Abdelrahman I Zain-Alabdeen, et al.
Drug Development Research|March 28, 2026
TRIM47 Promotes Atherosclerosis by Activating NF-κB Signaling via IκBα UbiquitinationXiaoming Qin, Jiachen Luo, Yiqian Yuan, et al.
Pageof 138